Advertisement

Now Playing

Analyst Moves: LLY, LXK

Analyst Moves: LLY, LXK

Eli Lilly (LLY) had its price target increased by Bank of America/Merrill Lynch due to Ramucirumab's potential as a successful cancer drug. A $52 price target was issued with a buy rating.

Most Recent Money Videos

Previous Next
Back to All Genres

Browse Money Videos

Analyst Moves: KFT, CPN

April 30 - Kraft (KFT) was upgraded today by JP Morgan (JPM) to...

runtime: 00:48

More From: Market News Video

Wednesday 2/6 Insider Buying...

February 6 - Bargain hunters are wise to pay careful attention to...

runtime: 00:41

More From: Market News Video

Thursday 4/5 Insider Buying...

April 5 - As the saying goes, there are many possible reasons for...

runtime: 01:13

More From: Market News Video

Thursday 3/8 Insider Buying...

March 8 - As the saying goes, there are many possible reasons for...

runtime: 01:21

More From: Market News Video

Analyst Moves: TSN, BIIB

January 29 - Tyson Foods (TSN) was upgraded by Bank of...

runtime: 00:37

More From: Market News Video

Tuesday 10/9 Insider Buying...

October 9 - Bargain hunters are wise to pay careful attention to...

runtime: 00:54

More From: Market News Video

Analyst Moves: GBX, ZION

January 10 - The Greenbrier Companies (GBX) had its price target...

runtime: 00:36

More From: Market News Video

Daily Market Wrap: April 5, 2012

April 5 - After two days of declines, the markets struggled to...

runtime: 00:58

More From: Market News Video

Analyst Moves: XOM, DFS

March 22 - Exxon Mobil (XOM) was upgraded today by JP Morgan (JPM)...

runtime: 00:41

More From: Market News Video

Cardinal Health Announces Earnings

February 5 - Cardinal Health (CAH) announced that second fiscal...

runtime: 00:42

More From: Market News Video

Dumb Real Estate Moves: Sellers

March 28 - With real estate prices in most markets bumping along...

runtime: 01:43

More From: Money Talks News

Foreclosure Feast: How the Rich...

April 5 - FHA is selling homes for cheap - but not to you.

runtime: 01:54

More From: Money Talks News